Cargando…
Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry
SARS-CoV-2 Spike harbors glycans which function as ligands for lectins. Therefore, it should be possible to exploit lectins to target SARS-CoV-2 and inhibit cellular entry by binding glycans on the Spike protein. Burkholderia oklahomensis agglutinin (BOA) is an antiviral lectin that interacts with v...
Autores principales: | Guseman, Alex J., Rennick, Linda J., Nambulli, Sham, Roy, Chandra N., Martinez, David R., Yang, Darian T., Bhinderwhala, Fatema, Vergara, Sandra, Baric, Ralph S., Ambrose, Zandrea, Duprex, W. Paul, Gronenborn, Angela M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810211/ https://www.ncbi.nlm.nih.gov/pubmed/36597530 http://dx.doi.org/10.1101/2022.12.22.521642 |
Ejemplares similares
-
Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry
por: Guseman, Alex, et al.
Publicado: (2023) -
Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023) -
Developing lectins as inhibitors of SARS-CoV2
por: Guseman, Alex J., et al.
Publicado: (2022) -
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
por: McCarthy, Kevin R., et al.
Publicado: (2021) -
Chronic Infection of Domestic Cats with Feline Morbillivirus, United States
por: Sharp, Claire R., et al.
Publicado: (2016)